IBD Clinic of the Future

June 11, 2020

Watch the video below to get the latest recommendations for people affected by Crohn's or colitis. Experts discuss how IBD clinics will change post COVID-19, what they have learned from COVID-19 to improve patient care, and what this means for patients in the future including virtual care, testing and disease monitoring.

 

  • Moderators

    Dr. Gilaad Kaplan (MD, MPH, FRCPC), Professor of Medicine, Gastroenterologist and Epidemiologist, Departments of Medicine and Community Health Sciences, University of Calgary, Chair, Scientific and Medical Advisory Council, Crohn's and Colitis Canada

    Dr. Eric Benchimol (MD, PhD., FRCPC), Associate Professor and Gastroenterologist, Department of Pediatrics and School of Epidemiology and Public Health at the University of Ottawa, Division of Gastroenterology at Children's Hospital of Eastern Ontario (CHEO), NASPGHAN Canadian Councilor

    Panelists:

    Dr. Kerri Novak (MD, FRCPC), Clinical Associate Professor, Department of Medicine, University of Calgary, Division of Gastroenterology and Hepatology, Inflammatory Bowel Disease Group, Foothills Medical Centre

    Dr. Maria Abreu (MD), Clinical Professor, Division of Gastroenterology, Director of the Crohn's and Colitis Center, University of Miami Miller School of Medicine, Recipient of the 2019 Sherman Prize

    Dr. John Marshall (MD, MSc, FRCPC, AGAF), Professor, Director of the Division of Gastroenterology at McMaster University


If you require further assistance, please click here.

Dr Benchimol and Dr Kaplan photos

Want to help boost our research initiatives?

Text CURE to 20222 to donate $25 to Crohn’s and Colitis Canada’s critical research projects.

READ MORE

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.